{"anticipatedPostingDate":"2010-06","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"description":"Includes patients (with non-Hodgkin leukemia or chronic lymphocytic leukemia) whose disease progressed after treatment.","groups":[{"description":"Patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with donor natural killer cells infusion, rituximab, aldesleukin and chemotherapy who had a response to treatment (clinical response or partial response).","id":"OG000","title":"Responder Patients"}],"paramType":"NUMBER","populationDescription":"Only patients who responded to treatment included in the analysis.","reportingStatus":"POSTED","timeFrame":"6 Months","title":"Number of Patients Whose Disease Progressed After Treatment","type":"SECONDARY","unitOfMeasure":"Participants"}